Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Michael J. Fisher, M.D.

Michael J. Fisher, M.D.

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 10th Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: (215)590-2800
Education:

Eberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
M.D.
Harvard Medical School (cum Laude), 1994.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Weiss B, Widemann BC, Wolters P, Dombi E, Vinks AA, Cantor A, Korf B, Perentesis J, Gutmann DH, Schorry E, Packer R, Fisher MJ: Sirolimus for non-Progressive NF1-Associated Plexiform Neurofibromas: An NF Clinical Trials Consortium Phase II Study. Pediatric Blood & Cancer 61: 982–986, 2014.

Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath JA, McCowage G, Cohn RJ, Fisher MJ, Robinson G, Broniscer A, Gajjar A, Gurney JG: Concordance between the Chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma. Pediatric Blood & Cancer 61(4): 601–605, 2014.

Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G, Rood BR, Packer RJ: Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatric Blood & Cancer 60(5): 776-782, September 2013.

de Blank PMK, Berman JI, Liu GT, Roberts TP, Fisher MJ: Fractional Anisotropy of the Optic Radiations is Associated with Visual Acuity Loss in Optic Pathway Gliomas of Neurofibromatosis Type 1. Neuro-Oncol 15(8): 1088-95, August 2013.

Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AA : Population Pharmacokinetics of Sirolimus in Pediatric Patients With Neurofibromatosis Type 1. Ther Drug Monit 35(3): 332-337, June 2013.

Plotkin SR, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Widemann BC: Achieving Consensus for Clinical Trials: the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. Neurology 81((Suppl 1)): S1–S5, 2013.

Fisher MJ, Avery RA, Allen JC, Ardern-Holmes SL, Bilaniuk LT, Ferner RE, Gutmann DH, Listernick R, Martin S, Ullrich NJ, Liu GT, for the REiNS International Collaboration: Functional outcome measures for NF1-Associated Optic Pathway Glioma Clinical Trials. Neurology 81((Suppl 1)): S15–S24, 2013.

Widemann BC, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Plotkin SR: Future Directions for the REiNS International Consortium. Neurology 81((Suppl 1)): S41–S44, 2013.

Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, Barker FG, Connor S, Evans DG, Fisher MJ, Goutagny S, Harris GJ, Jaramillo D, Karajannis MA, Korf BR, Mautner V, Plotkin SR, Poussaint TY, Robertson K, Shih C-S, Widemann BC, for the REiNS International Collaboration: Recommendations for Imaging Tumor Response in Neurofibromatosis Clinical Trials. Neurology 81((Suppl 1)): S33–S40, 2013.

Kranick SM, Campen CJ, Kasner SE, Kessler SK, Zimmerman RA, Lustig RA, Phillips PC, Beslow LA, Ichord R, Fisher MJ: Headache as a Risk Factor for Neurovascular Events in Pediatric Brain Tumor Patients. Neurology 80(16): 1452-1456, 2013.

back to top
Last updated: 04/18/2014
The Trustees of the University of Pennsylvania